Neuroprotective Qualities of Masitinib Drug in Stroke Encouraging For MS Indication

An encouraging experimental drug that is being developed for Multiple Sclerosis continues to show promise in being able to offer neuroprotective benefits — an effect that could slow and eventually cure MS.Ā Masitinib,Ā which is being developed by AB Science forĀ numerous neurological indications, including Alzheimer’s disease, progressive multiple sclerosis, and amyotrophic…

MS Society Canada Urges Parliamentarians to Improve MS Clinics

While Canada is home to one of the world’s most comprehensive social healthcare systems, it is unfortunately home to one of the largestĀ multiple sclerosisĀ patient populations as well. According to the Multiple Sclerosis Society of Canada, at least 100,000 Canadians have the disease, and at least 20,000 of them live…

Opexa Joins National Multiple Sclerosis Society to Sponsor Walk MS

The National Multiple Sclerosis Society‘sĀ Lone Star Chapter, which is sponsoring theĀ nonprofit organizationā€™s annualĀ Houston-area Walk MSĀ fundraisers, has announced that Woodlands-based biopharmaceutical companyĀ Opexa Therapeutics, a company currently developing personalized immunotherapies for multiple sclerosis (MS), will also support the fundraising effort. This is the fourth consecutive…

Study Finds No Link Between Vaccines and Multiple Sclerosis

A new study entitled, ā€œVaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseasesā€ published in theĀ JAMA Neurology journal, reports that no association was observed between vaccinations and an increased risk for Multiple Sclerosis or other central nervous system…

Dimension Data Helps Raise $130K for National MS Society

One of the most effective and engaging fundraising strategies the National Multiple Sclerosis Society organizes annually is the Bike MS series. Several times a year, in different locations throughout the country, thousands of MS patients from all over the world, as well as friends, family, and advocacy…

MS Blueprint Online Program by Biogen Helps Patients Live Happier

Cambridge, Massachusetts-basedĀ Biogen IdecĀ has just announced a new support program for people living with multiple sclerosis (MS) that encourages patients to turn their attention to daily activities that enhance their emotional and mental state. The newly launched MS Blueprint program assists patients and caregivers in setting positive and realistic goals,…

5-Course Dinner Raises $445K for Multiple Sclerosis Society of Canada

Heartwarming support for multiple sclerosis campaigns and charity events poured in at last week’s exclusive gastronomic fundraising event, theĀ ToquĆ©! for MSĀ benefit, made possible by the tireless, collaborative efforts of Louis Vachon, the event’s Honorary Chair and President and CEO of the National Bank, andĀ ToquĆ©! Restaurant’s Grand Chef Relais & ChĆ¢teaux,…

Free Continuing Education for MS Care Providers Starts in November

Several national health organizations have come together to design a series of continuing education opportunities focused on better managing multiple sclerosis entitled,Ā Optimizing Multiple Sclerosis Management.Ā Thanks to the collaborative efforts of leading MS organization for professionals, the Consortium of Multiple Sclerosis Centers (CMSC); Nurse Practitioner Alternatives (NPA), and Spire Learning, allied…

Revenge Star Madeleine Stowe is the New Face of Multiple Sclerosis

Featureflash / Shutterstock.com Television’s “Queen of Mean,” Revenge‘s Madeleine Stowe,Ā recently opened up about her early memories of her father living with multiple sclerosis (MS), a progressive neurodegenerative disease that, until today, does not have a known cure. However, thanks to the efforts of countless researchers and MS…

Spasticity Drug to be Tested on Multiple Sclerosis Patients in Early 2015

Concert Pharmaceuticals, Inc. will announce their latest results from the Phase 1 data of CTP-354, a drug developed to treat spasticity ā€” a chronic condition associated with patients with brain disorders, including Multiple Sclerosis —Ā at the next American Neurological Associationā€™s Annual Meeting in Baltimore, Maryland. The Phase 1 randomized,…

Ankar Pharma Opens Crowdfunding for Promising MS Drug

Spanish-Filipino biopharmaceutical startupĀ Ankar PharmaĀ is working on a promising treatment for multiple sclerosis (MS). Dr. Ana Martinez, a professor and researcher at theĀ Biological Research Center (CIB) of the Spanish National Council for Research (CSIC), explains that while there are several palliative treatments available on the market…

PHARMAC Approves Funding New RRMS Treatments in New Zealand

New Zealand-basedĀ Pharmaceutical Management Agency (PHARMAC) has approved the funding of new treatments for multiple sclerosis (MS), which are expected not only to reach more patients, but also be more effective in curtailing the disease’s progressive symptoms. The therapies currently funded are meant for the treatment ofĀ …

Alabama Representative Honored at National MS Society Ball

The National Multiple Sclerosis SocietyĀ recently honored several admirable MS advocates and leaders during the annual NMSS Ambassadors Ball, held in Washington, D.C., to benefit local MS patients and research initiatives. The upscale black-tie evening brought together some of the most accomplished industry leaders and celebrities at the Georgetown Ritz…

Why NAD+ Could Become a New Multiple Sclerosis Therapy

A new study entitled ā€œNAD+ protects against EAE by regulating CD4+ T-cell differentiationā€ published in October issue of Nature Communications reports that NAD+ can be a future therapeutic drug to treat Multiple Sclerosis. Multiple sclerosis (MS) is a type of autoimmune disease where the inner…